by Xcellerant Ventures | May 31, 2023 | Portfolio Company News
https://nanodropper.com/published-study-reflects-nanodroppers-significant-impact-on-eyedrop-waste-reduction/ Content origionally posted on Nanodropper’s blog: Nanodropper, an ophthalmic device company that makes the eyedrop volume-reducing Nanodropper...
by Xcellerant Ventures | May 23, 2023 | Portfolio Company News
Content origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/anuncia-medical-inc-announces-published-data-with-promising-clinical-outcomes-using-the-reflow-ventricular-system-in-line-with-hydrocephalus-shunts-301832020.html SCOTTSDALE,...
by Xcellerant Ventures | May 23, 2023 | Portfolio Company News
Podcast was origionally posted by Greenlight Guru: https://www.angelinvestboston.com/dom-messerli-treating-spinal-fractures-better Spinal fractures from osteoporosis cause many to lose their independence. Industry veteran Dom Messerli has a better way of fixing the...
by Xcellerant Ventures | May 11, 2023 | Portfolio Company News
Orgionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-new-test-that-can-identify-those-in-most-danger-from-covid-19-301821712.html PHOENIX, May 11, 2023 /PRNewswire/ — Tesis Biosciences, the leader in targeted genetic...
by Xcellerant Ventures | May 3, 2023 | Portfolio Company News
Article origionally posted on Business Wire: https://www.businesswire.com/news/home/20230503005191/en/Paragraf-Acquires-CRISPR-Chip-Developer-Cardea-Bio-Accelerating-CRISPR-QC%E2%80%99s-Business-Opportunity SAN DIEGO–(BUSINESS WIRE)–Today, CRISPR QC...
by Xcellerant Ventures | Apr 20, 2023 | Portfolio Company News
Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-a-novel-pharmacogenomics-test-enabling-precise-personalized-response-to-wide-range-of-pharmaceuticals-301802763.html PHOENIX, April 20, 2023 /PRNewswire/...
